Novartis, Merck and Allergan join those raising U.S. drug prices for 2020

3 Jan 2020

Novartis AG, Merck & Co
Inc and Allergan Plc were among companies that
raised U.S. prices on more than 100 prescription medicines on
Friday, bringing the tally to 445 drugs that will cost more in
2020, according to data analyzed by healthcare research firm 3
Axis Advisors.

Read full article at Reuters